Toripalimab · Medicine question

Which adults with oesophageal squamous cell carcinoma is LOQTORZI (toripalimab) indicated to treat?

Name: Which adults with oesophageal squamous cell carcinoma is LOQTORZI (toripalimab) indicated to treat?
Published: 2026-11-08T01:30:33.265Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

LOQTORZI (toripalimab), combined with cisplatin and paclitaxel, is indicated for first-line treatment of adults with unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma.

Sources for this answer

LOQTORZI 240 mg concentrate for solution for infusionTopalliance Biosciences Europe Limited · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated 24 March 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about Toripalimab